Cunjian Yi

650 total citations
26 papers, 194 citations indexed

About

Cunjian Yi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Cunjian Yi has authored 26 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Cunjian Yi's work include Cancer-related molecular mechanisms research (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Cunjian Yi is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Cunjian Yi collaborates with scholars based in China, United States and South Korea. Cunjian Yi's co-authors include Jie Tan, Yi Xu, Xinling Zeng, Ya Wang, Xiangqiong Liu, Youn Seok Choi, Jinzhi Lu, Keming Chen, Jeong‐Im Sin and Hongyan Wu and has published in prestigious journals such as PLoS ONE, Medicine and Frontiers in Oncology.

In The Last Decade

Cunjian Yi

24 papers receiving 192 citations

Peers

Cunjian Yi

ONCOL

Nikola Hájková Czechia

Tong Shu China

Imre Pete Hungary

Te-Sheng Chang Taiwan

Jinxiao Liang China

Irene Campoy Spain

David Huntsman Canada

Xuan Pei China

Haruko Kunitomi Japan

Chunfang Ha China

Nikola Hájková Czechia

Cunjian Yi

79 ×0.9

37 ×0.6

69 ×1.6

ONCOL

44 ×1.0

61 ×2.0

Citations per year, relative to Cunjian Yi Cunjian Yi (= 1×) peers Nikola Hájková

Countries citing papers authored by Cunjian Yi

Since Specialization

Citations

This map shows the geographic impact of Cunjian Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cunjian Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cunjian Yi more than expected).

Fields of papers citing papers by Cunjian Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cunjian Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cunjian Yi. The network helps show where Cunjian Yi may publish in the future.

Co-authorship network of co-authors of Cunjian Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Cunjian Yi. A scholar is included among the top collaborators of Cunjian Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cunjian Yi. Cunjian Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Jifeng, Yirong Zhang, Cunjian Yi, et al.. (2025). Ring artifact suppression and removal algorithm for an X-ray cone beam CT system. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 1072. 170217–170217.

Yi, Cunjian, et al.. (2024). The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications. Frontiers in Oncology. 14. 1332528–1332528. 3 indexed citations

Yi, Cunjian, et al.. (2023). Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis. Cancer Medicine. 12(7). 9024–9040. 8 indexed citations

Li, Wenzhe, Yi Xu, Xinling Zeng, et al.. (2023). Etiological relationship between lipid metabolism and endometrial carcinoma. Lipids in Health and Disease. 22(1). 116–116. 15 indexed citations

Wang, Xiaowen, Jian Liu, Keming Chen, et al.. (2021). Prognostic Factors in COVID-19 Pneumonia with Severe Acute Respiratory Distress Syndrome: An Observational Study. 5(4). 249–265.

Lu, Huijuan & Cunjian Yi. (2021). Herlyn-Werner-Wunderlich Syndrome: A Case of Report and Literature Review. Case Reports in Clinical Medicine. 10(11). 365–372. 1 indexed citations

Wang, Ya, Jie Tan, Cheng Xu, et al.. (2021). Identification and construction of lncRNA-associated ceRNA network in diabetic kidney disease. Medicine. 100(22). e26062–e26062. 10 indexed citations

Zeng, Yong, Bo Zhang, Xu‐Feng Zhang, & Cunjian Yi. (2020). Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection. Chinese Medicine. 15(1). 47–47. 8 indexed citations

Wei, Hua, et al.. (2017). Expressional profile of apoptosis and anti-apoptosis proteins in polycystic ovary syndrome patients and related mechanisms. Biomedical Research-tokyo. 28(18). 7930–7935. 4 indexed citations

10.

Dong, Ling-Dan, et al.. (2017). Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma. Oncology Letters. 13(4). 2109–2114. 5 indexed citations

11.

Lu, Jinzhi, Fang Xie, Liya Zhu, et al.. (2016). Mild oxidative stress induced by a low dose of cisplatin contributes to the escape of TRAIL-mediated apoptosis in the ovarian cancer SKOV3 cell line. Oncology Reports. 35(6). 3427–3434. 4 indexed citations

12.

Lu, Jinzhi, Liya Zhu, Lei Zhang, et al.. (2016). Abnormal Expression of TRAIL Receptors in Decidual Tissue of Chlamydia trachomatis-Infected Rats During Early Pregnancy Loss. Reproductive Sciences. 24(7). 1041–1052. 3 indexed citations

13.

Shen, Ying‐Chun, Yingchao Zhao, Hongfeng Gou, et al.. (2015). Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial. European Journal of Surgical Oncology. 41(8). 1082–1088. 16 indexed citations

14.

Chen, Keming, et al.. (2014). Expression and significance of transforming growth factor-β1 in epithelial ovarian cancer and its extracellular matrix. Oncology Letters. 8(5). 2171–2174. 9 indexed citations

15.

Yi, Cunjian, Lei Zhang, Li Li, et al.. (2014). Establishment of an orthotopic transplantation tumor model in nude mice using a drug-resistant human ovarian cancer cell line with a high expression of c-Kit. Oncology Letters. 8(6). 2611–2615. 7 indexed citations

16.

Yi, Cunjian, Li Li, Xiaowen Wang, & Xiangqiong Liu. (2014). Laparoscopic postoperative complication: Recurrence of endometrium & leiomyoma from tissue residues. Pakistan Journal of Medical Sciences. 30(5). 1134–6. 6 indexed citations

17.

Yi, Cunjian, Lei Zhang, Fayun Zhang, et al.. (2014). Methodologies for the establishment of an orthotopic transplantation model of ovarian cancer in mice. Frontiers of Medicine. 8(1). 101–105. 4 indexed citations

18.

Fan, Wen, Lei Xu, Decai Yang, et al.. (2014). Negative Interference by Rheumatoid Factor of Plasma B-Type Natriuretic Peptide in Chemiluminescent Microparticle Immunoassays. PLoS ONE. 9(8). e105304–e105304. 6 indexed citations

19.

Yi, Cunjian, et al.. (2011). Expression of c-Kit and PDGFRα in epithelial ovarian tumors and tumor stroma. Oncology Letters. 3(2). 369–372. 9 indexed citations

20.

Choi, Youn Seok, et al.. (2006). Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging. International Journal of Gynecological Cancer. 16(5). 1846–1854. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact